Brixadi Alternatives Compared
| Brixadi (buprenorphine) | Suboxone (buprenorphine / naloxone) | Buprenorphine / naloxone |
|
|---|
| Brixadi (buprenorphine) | Suboxone (buprenorphine / naloxone) | Buprenorphine / naloxone |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Opiate Dependence - Maintenance, Opioid Use Disorder. Brixadi may also be used for purposes not listed in this medication guide. |
Prescription only
Suboxone is a combination medicine containing buprenorphine and naloxone that is used to treat adults addicted to opioid medications. It should be used in conjunction with a complete treatment... View more |
Prescription only
Buprenorphine/naloxone is a combination opioid/opioid antagonist tablet which helps to suppress opioid withdrawal symptoms and is used for the maintenance treatment of opioid drug dependence... View more |
Related suggestions Opioid Use Disorder
Popular comparisons
|
|||||||||||||||||||||||
| More about Brixadi (buprenorphine) | More about Suboxone (buprenorphine / naloxone) | More about Buprenorphine / naloxone | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Brixadi has an average rating of 6.0 out of 10 from a total of 2 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 0% reported a negative effect. |
Suboxone has an average rating of 8.5 out of 10 from a total of 731 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 7% reported a negative effect. |
Buprenorphine / naloxone has an average rating of 7.7 out of 10 from a total of 1133 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 16% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Brixadi side effects |
View all Suboxone side effects |
|
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
|
None |
||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Brixadi prices |
View all Suboxone prices |
View all Buprenorphine / naloxone prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other buprenorphine brands include: Belbuca, Buprenex, Butrans, Sublocade | Other buprenorphine / naloxone brands include: Zubsolv | Suboxone, Zubsolv | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
48 hours |
37 hours |
37 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 726 drugs are known to interact with Brixadi:
|
A total of 731 drugs are known to interact with Suboxone:
|
A total of 731 drugs are known to interact with Buprenorphine / naloxone:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
May 23, 2023 |
October 08, 2002 |
October 08, 2002 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.